Advocacy

SDPA is concerned about the Centers for Medicare & Medicaid Services' (CMS) proposed CY 2027 Medicare Physician Fee Schedule changes. Specifically, SDPA opposes reductions to the Physician Fee Schedule conversion factors and the proposed payment cuts for same-day evaluation and management services and global surgical procedures reported with Modifier 25. These proposals threaten fair reimbursement for the high-quality, timely care SDPA members provide to patients.

The Society of Dermatology Physician Assistants (SDPA) recognizes emerging evidence on potential adverse effects associated with prolonged topical corticosteroid use in managing chronic inflammatory dermatoses. These findings highlight the need for vigilant treatment planning to mitigate long-term risks. To prioritize patient safety and optimize outcomes, the SDPA advocates for routine assessment of cumulative steroid exposure as a cornerstone of patient care.